EP Patent

EP4335505A2 — Anticonvulsant activity of steroids

Assigned to University of California · Expires 2024-03-13 · 2y expired

What this patent protects

The present invention relates to methods of preventing, inhibiting, delaying, and/or mitigating seizures by administration of a steroid, e.g., a neurosteroid, e . g ., allopregnanolone.

USPTO Abstract

The present invention relates to methods of preventing, inhibiting, delaying, and/or mitigating seizures by administration of a steroid, e.g., a neurosteroid, e . g ., allopregnanolone.

Drugs covered by this patent

Patent Metadata

Patent number
EP4335505A2
Jurisdiction
EP
Classification
—
Expires
2024-03-13
Drug substance claim
No
Drug product claim
No
Assignee
University of California
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.